In the long-term toxicity experiment, continuous injection of AOD 9604 (10 mg/kg) for 8 weeks did not cause abnormal liver and kidney functions or fluctuations in blood glucose, providing a safety basis for its further research and application
[DOI] [PubMed] [Google Scholar] [232].Michishita E, Park JY, Burneskis JM, Barrett JC, Horikawa I
De Block C, Bailey C, Wysham C, Hemmingway A, Allen SE, Peleshok J (2022) Tirzepatide for the treatment of adults with type 2 diabetes: an endocrine perspective
The more options people have, the better, says Avlin Imaeda, MD, PhD, a Yale Medicine gastroenterologist who is board-certified in obesity medicine
The results showed that the treatment with Ru(II)-OH reduced the tumor volume by 35%, the treatment with NP2 by 66%, and the treatment with NP4 by 91% (Fig